Questioning the renoprotective role of L-type calcium channel blockers in chronic kidney disease using physiological modeling
Keyword(s):
Our physiological model replicates clinical trial results and provides unique insights into possible mechanisms that play a role in glomerular injury and hypertensive kidney disease progression during chronic calcium channel blocker (CCB) therapy. Specifically, these simulations predict the temporal changes in renal function with CCB treatment and demonstrate important roles for tubuloglomerular feedback and efferent arteriolar conductance in the control of chronic kidney disease progression.
2009 ◽
Vol 19
(1)
◽
pp. 33-37
◽
2010 ◽
Vol 19
(9)
◽
pp. 1027-1037
◽